+29.1%
MRNA vs SN
+349.8%
-320.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -4.0% | +4.7% | +1.6% |
| 7D | -8.2% | -7.2% | -1.0% | -6.7% |
| 30D | +125.6% | -13.4% | +138.9% | +131.9% |
| 3M | +197.1% | +26.8% | +170.3% | +174.3% |
| 6M | +148.5% | +44.6% | +103.9% | +120.1% |
| YTD | +363.3% | +45.3% | +318.0% | +307.7% |
| 1Y | +462.0% | +40.1% | +421.9% | +398.2% |
| All | +29.1% | +349.8% | -320.7% | -7.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SN.
Daily Out/Under-Performance
Portfolio return minus SN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling